Pancreatic Cancer Research

ReviewBMC Cancer2021

Meta-analysis and indirect treatment comparison of modified FOLFIRINOX and gemcitabine plus nab-paclitaxel as first-line chemotherapy in advanced pancreatic cancer.

Journal
BMC Cancer
Published
23 July 2021
Citations
13
Type
Review
License
cc by
Full text
Open access, reuse-licensed (cc by)

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Its licensed text is not loaded here yet, so most questions will be declined.

Try